Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

34.62
Delayed Data
As of Oct 20
 -0.09 / -0.26%
Today’s Change
25.55
Today|||52-Week Range
35.60
+26.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues5.3B5.1B5.2B5.2B
 
 
 
 
 
Cost of Goods Sold212.0M480.4M189.4M296.9M
 
 
 
 
 
Depreciation And Amortization563.1M537.8M629.4M628.5M
 
 
 
 
 
 
Operating ExpensesGross Income4.5B4.1B4.4B4.2B
 
 
 
 
 
General Expenses3.4B2.4B3.5B3.7B
 
 
 
 
 
Other Operating Expenses19.4M20.1M--0.00
 
 
 
Research And Development1.3B1.4B1.3B1.3B
 
 
 
 
 
Total Operating Expenses4.2B3.5B4.3B4.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.1B1.6B877.1M516.3M
 
 
 
 
 
Extraordinary Credit22.1M0.000.000.00
 
 
Extraordinary Charge-252.5M-359.2M-298.4M-187.7M
 
 
 
 
 
Interest Expense On Debt327.1M330.0M325.2M457.1M
 
 
 
 
 
Equity In Earnings-9.2M-10.0M-12.4M-13.3M
 
 
 
 
 
Other Expenses98.6M1.0B298.4M615.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income632.2M2.0B569.1M515.3M
 
 
 
 
 
Income Taxes-294.0M-333.6M-67.0M-46.9M
 
 
 
 
 
Minority Interest-17.5M-22.8M-23.9M-31.6M
 
 
 
 
 
Net Income934.4M1.7B513.6M486.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.37$0.67$0.20$0.19
 
 
 
 
 
EPS Diluted$0.37$0.66$0.20$0.19